S&P 500
7,483.80
+0.45%
Dow Jones
52,056.40
+0.26%
Nasdaq 100
28,940.20
+1.09%
Russell 2000
2,962.72
+0.66%
FTSE 100
10,506.00
+0.41%
Nikkei 225
66,193.70
+1.68%

Investing

CGC logo Canopy Growth : CGC

CGC

Stock Data

$0.93

Change down

$0.01 (0.64%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

DRUG MANUFACTURERS - SPECIALTY & GENERIC

Canopy Growth Corporation is engaged in the production, distribution and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. The company is headquartered in Smiths Falls, Canada.

Latest Activity

CGCCanopy Growth Corp
Q4 2026
EPS
-$0.40
est -$0.09-$0.32
Revenue
$71M
est $74M-4.2%

Canopy Growth is on the cusp of profitability after losses of $0.40 per share, banking on a 68% surge in international cannabis sales and a strengthened $131.3M net cash balance to reach positive adjusted EBITDA in FY2027. CEO Luc Mongeau framed the turnaround bluntly: the company reset, cut costs, and made strategic bets including the MTL Cannabis acquisition that position it to extend medical cannabis leadership from Canada into Europe.

CGC share price
Read more

All Canopy Growth Articles

80 Articles

1 2 3 … 6